HOME >> BIOLOGY >> NEWS
Gene may produce drought-resistant plants

WEST LAFAYETTE, Ind. - The identification and duplication of a gene that controls production of plants' outermost protective coating may allow Purdue University researchers to create crops with increased drought resistance.

Scientists cloned the gene WAX2 after they discovered a fast-wilting mutant of Arabidopsis, a commonly used experimental plant. The gene is directly associated with the synthesis of the protective layer of plants, called the cuticle, and its contained waxes, according to the study published in the May issue of The Plant Cell.

The difference in the mutant Arabidopsis when compared to a wild-type, or normal, plant is the plants' ability to retain water. This is apparently because the mutation, called wax2, has a different cuticle structure than found in a plant that has the normal gene, WAX2.

"If we can alter the expression of the WAX2 gene, we might be able to produce a cuticle that is thicker or more rigid so that it's less permeable to water loss," said Matt Jenks, associate professor of horticulture and landscape architecture.

Manipulating what the gene does or when it is turned on could result in plants better able to survive in arid conditions.

Jenks and his research team isolated more than 20 mutant Arabidopsis plants that showed alterations in the amount of wax they produced. Of these, only a few lost water more quickly than the wild type.

"The mutant wax2 was the most drought susceptible," Jenks said. "Unlike previously described wax mutants, removal of the WAX2 gene product causes dramatic alteration in the cuticle membrane, and the plant no longer is able to prevent water loss."

Jenks said he believes that when the cuticle membrane structure is changed because of the wax2 malfunction of the WAX2 gene, the protective wax within the cuticle membrane is displaced, affecting transpiration. Transpiration is how plants emit waste matter though their leaf surfaces.

"It's likely t
'"/>

Contact: Susan A. Steeves
ssteeves@aes.purdue.edu
765-496-7481
Purdue University
21-May-2003


Page: 1 2

Related biology news :

1. Genetic modification of linseed produces healthier omega 3 and 6 fatty acids
2. Spontaneous mutation produces new MAO A/B knockout mouse
3. Scientists reinvent DNA as template to produce organic molecules
4. Therapeutic cloning no longer a dream, says scientist who produced first cloned embryonic stem cell
5. Synthetic hormone used in contraceptives and HRT produces negative effects in monkey studies
6. Biologists discover nerve activity, not just genetics controls kinds of neurotransmitters produced
7. Tigecycline - Candidate antibiotic produces 74 percent cure rate in cSSSI patients
8. First genetic comparison of purebred domestic dogs produces surprises
9. Biological computer diagnoses cancer and produces drug in a test tube
10. High-fat fast-food breakfast produces rush of inflammatory factors into blood stream, UB study finds
11. Oil exploitation in Ecuadors Amazon basin produces a public health emergency

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Gene may produce drought resistant plants

(Date:6/16/2015)... , June 16, 2015 /CNW Telbec/ - handyem ... centralized around the incorporation of handyem,s HPC-150 portable ... laboratory, the Mo-POD™. This unprecedented model of mobile ... Conference at the Pennsylvania ... June 15 th to 18 th ...
(Date:6/16/2015)... , June 16, 2015 Fingerprint Cards ... fingerprint sensors in the company,s portfolio from one of its ... planned to mainly take place during the third quarter 2015. ... Asia . Jörgen Lantto, CEO of ...   the   growing interest from smartphone OEMs in integrating ...
(Date:6/15/2015)... June 16, 2015 According to ... by Type (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, IVR, ... 2020" published by MarketsandMarkets, The Natural Language Processing Market ... CAGR of 18.4% for the forecast period 2015-2020. ... 46 F igures spread   through 155 P ...
Breaking Biology News(10 mins):handyem and FlowMetric Diagnostics announce their partnership in the development of Flow Cytometry- Based Solutions in diagnostic capabilities 2handyem and FlowMetric Diagnostics announce their partnership in the development of Flow Cytometry- Based Solutions in diagnostic capabilities 3FPC Receives Order for Touch Fingerprint Sensors of 375 MSEK 2Natural Language Processing Market Worth $13.4 Billion by 2020 2Natural Language Processing Market Worth $13.4 Billion by 2020 3Natural Language Processing Market Worth $13.4 Billion by 2020 4Natural Language Processing Market Worth $13.4 Billion by 2020 5
(Date:7/2/2015)... ... July 02, 2015 , ... In’Tech ... surgical instruments in Orthopedics, announced today the acquisition of Turner Medical, Inc ... provider of surgical instruments to the Spine Industry. The acquisition of Turner Medical ...
(Date:7/1/2015)... , July 1, 2015   Decision ... frequently cited advantages of Otezla are its oral ... profile, as reported by surveyed rheumatologists. Otezla was ... for the treatment of active psoriatic arthritis in ... current standard of care includes conventional oral treatments ...
(Date:7/1/2015)... ALTO, Calif. , July 1, 2015 /PRNewswire/ ... focused on the development of groundbreaking drugs to ... (ALS), announced today that Robert G. Miller ... Center at Sutter Health,s California Pacific Medical Center ... The ALS Association for $1.5 million to help ...
(Date:7/1/2015)... ... July 01, 2015 , ... A newly launched business plan ... lower the barriers to innovation in life sciences R&D. The Pistoia Alliance President’s Startup ... prizes of US$15,000 and a period of expert mentorship from a senior industry figure ...
Breaking Biology Technology:In'Tech Medical Acquires Turner Medical to Become a World Leader in Orthopedic Contract-Manufacturing 2In'Tech Medical Acquires Turner Medical to Become a World Leader in Orthopedic Contract-Manufacturing 3Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 2Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 2Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 4Pistoia Alliance Launches Startup Challenge 2Pistoia Alliance Launches Startup Challenge 3
Cached News: